For this assignment, you will develop a patient medication guide for treatment of depressive disorders in a vulnerable population (your choice for one vulnerable patient population to choose from: children, adolescents, older adults, dementia patients, pregnant women or one not listed of your choice!). Be sure to use language appropriate for your audience (patient, caregiver, parent, etc.). You will include non-copyright images and/or information tables to make your patient medication guide interesting and appealing. Limit your patient medication guide to 5 pages. You will create this guide as an assignment; therefore, a title page, introduction, conclusion, and reference page are required. You must include a minimum of 3 scholarly supporting resources outside of your course provided resources.
In your patient guide, include discussion on the following:
- Depressive disorder causes and symptoms
- How depression is diagnosed for the vulnerable population of your choice, why is this population considered vulnerable
- Medication treatment options including risk vs benefits; side effects; FDA approvals for the vulnerable population of your choice
- Medication considerations of medication examples prescribed (see last bullet item)
- What is important to monitor in terms of labs, comorbid medical issues with why important for monitoring
- Special Considerations (you must be specific, not general and address at least one for EACH category; you must demonstrate critical thinking beyond basics of HIPPA and informed consent!): legal considerations, ethical considerations, cultural considerations, social determinants of health
- Where to follow up in your local community for further information
- Provide 3 examples of how to write a proper prescription that you would provide to the patient or transmit to the pharmacy.
- Baek, J. H., Nierenberg, A. A., & Fava, M. (2016). Pharmacological approaches to treatment-resistant depression. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 44–47). Elsevier.
- Fava, M., & Papakostas, G. I. (2016). Antidepressants. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 27–43). Elsevier.
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.)Links to an external site.. https://doi.org/10.1176/appi.books.9780890425596
- Howland, R. H. (2008a). Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 1: Study design. Journal of Psychosocial Nursing and Mental Health ServicesLinks to an external site., 46(9), 21–24. https://doi.org/10.3928/02793695-20080901-06
- Howland, R. H. (2008b). Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes. Journal of Psychosocial Nursing and Mental Health ServicesLinks to an external site., 46(10), 21–24. https://doi.org/10.3928/02793695-20081001-05
- Lorberg, B., Davico, C., Martsenkovskyi, D., & Vitiello, B. (2019). Principles in using psychotropic medication in children and adolescents. In J. M. Rey & A. Martin (Eds.), IACAPAP e-textbook of child and adolescent mental healthLinks to an external site.. https://iacapap.org/_Resources/Persistent/45bdffb25befc353c9f61988e82105029504ab85/A.7-Psychopharmacology-2019.1.pdf
- Magellan Health. (2013). Appropriate use of psychotropic drugs in children and adolescents: A clinical monographLinks to an external site.. http://www.magellanhealth.com/media/445492/magellan-psychotropicdrugs-0203141.pdf
- Poznanski, E. O., & Mokros, H. B. (1996). Child depression rating scale—RevisedLinks to an external site.. Western Psychological Services.
- Rao, U. (2013). Biomarkers in pediatric depression. Depression & AnxietyLinks to an external site., 30(9), 787–791. https://doi.org/10.1002/da.22171
- Yasuda, S. U., Zhang, L. & Huang, S.-M. (2008). The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies. Clinical Pharmacology & TherapeuticsLinks to an external site., 84(3), 417–423. https://web.archive.org/web/20170809004704/https://www.fda.gov/downloads/Drugs/ScienceResearch/…/UCM085502.pdf
- U.S. Food & Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugsLinks to an external site.. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
Review the following medications:
- Doc Snipes. (2022, April 13). Major depressive disorders in the DSM 5 TRLinks to an external site. [Video]. YouTube. https://www.youtube.com/watch?v=q5Npw03I0t8
Note: The approximate length of this media piece is 59 minutes.
- Psych Hub. (2020, October 5). Social determinants of healthLinks to an external site. [Video]. YouTube. https://www.youtube.com/watch?v=17jeXGbKlTQ
Note: The approximate length of this media piece is 4 minutes.
- El Marroun, H., White, T., Verhulst, F., & Tiemeier, H. (2014). Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: A systematic review. European Child & Adolescent PsychiatryLinks to an external site., 23(10), 973–992. https://doi.org/10.1007/s00787-014-0558-3
- Gordon, M. S., & Melvin, G. A. (2014). Do antidepressants make children and adolescents suicidal? Journal of Pediatrics and Child HealthLinks to an external site., 50(11), 847–854. https://doi.org/10.1111/jpc.12655
- Seedat, S. (2014). Controversies in the use of antidepressants in children and adolescents: A decade since the storm and where do we stand now? Journal of Child & Adolescent Mental HealthLinks to an external site., 26(2),
All papers are written by ENL (US, UK, AUSTRALIA) writers with vast experience in the field. We perform a quality assessment on all orders before submitting them.
We provide plagiarism reports for all our custom written papers. All papers are written from scratch.
Contact us anytime, any day, via any means if you need any help. You can use the Live Chat, email, or our provided phone number anytime.
Get your money back if your paper is not delivered on time or if your instructions are not followed.